Cargando…
Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recog...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160936/ https://www.ncbi.nlm.nih.gov/pubmed/34069557 http://dx.doi.org/10.3390/jcm10102196 |
_version_ | 1783700395231543296 |
---|---|
author | Finance, Julie Zieleskewicz, Laurent Habert, Paul Jacquier, Alexis Parola, Philippe Boussuges, Alain Bregeon, Fabienne Eldin, Carole |
author_facet | Finance, Julie Zieleskewicz, Laurent Habert, Paul Jacquier, Alexis Parola, Philippe Boussuges, Alain Bregeon, Fabienne Eldin, Carole |
author_sort | Finance, Julie |
collection | PubMed |
description | Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recognised danger of ionising radiation. Method: To evaluate the role of low-dose computed tomography (LDCT) and lung ultrasound (LUS) in managing COVID-19 pneumonia, we performed a review of the literature including our cases. Results: Chest LDCT is now performed routinely when diagnosing and assessing the severity of COVID-19, allowing patients to be rapidly triaged. The extent of lung involvement assessed by LDCT is accurate in terms of predicting poor clinical outcomes in COVID-19-infected patients. Infectious disease specialists are less familiar with LUS, but this technique is also of great interest for a rapid diagnosis of patients with COVID-19 and is effective at assessing patient prognosis. Conclusions: COVID-19 is currently accelerating the transition to low-dose and “no-dose” imaging techniques to explore infectious pneumonia and their long-term consequences. |
format | Online Article Text |
id | pubmed-8160936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81609362021-05-29 Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 Finance, Julie Zieleskewicz, Laurent Habert, Paul Jacquier, Alexis Parola, Philippe Boussuges, Alain Bregeon, Fabienne Eldin, Carole J Clin Med Review Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recognised danger of ionising radiation. Method: To evaluate the role of low-dose computed tomography (LDCT) and lung ultrasound (LUS) in managing COVID-19 pneumonia, we performed a review of the literature including our cases. Results: Chest LDCT is now performed routinely when diagnosing and assessing the severity of COVID-19, allowing patients to be rapidly triaged. The extent of lung involvement assessed by LDCT is accurate in terms of predicting poor clinical outcomes in COVID-19-infected patients. Infectious disease specialists are less familiar with LUS, but this technique is also of great interest for a rapid diagnosis of patients with COVID-19 and is effective at assessing patient prognosis. Conclusions: COVID-19 is currently accelerating the transition to low-dose and “no-dose” imaging techniques to explore infectious pneumonia and their long-term consequences. MDPI 2021-05-19 /pmc/articles/PMC8160936/ /pubmed/34069557 http://dx.doi.org/10.3390/jcm10102196 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Finance, Julie Zieleskewicz, Laurent Habert, Paul Jacquier, Alexis Parola, Philippe Boussuges, Alain Bregeon, Fabienne Eldin, Carole Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 |
title | Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 |
title_full | Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 |
title_fullStr | Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 |
title_full_unstemmed | Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 |
title_short | Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 |
title_sort | low dose chest ct and lung ultrasound for the diagnosis and management of covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160936/ https://www.ncbi.nlm.nih.gov/pubmed/34069557 http://dx.doi.org/10.3390/jcm10102196 |
work_keys_str_mv | AT financejulie lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 AT zieleskewiczlaurent lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 AT habertpaul lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 AT jacquieralexis lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 AT parolaphilippe lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 AT boussugesalain lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 AT bregeonfabienne lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 AT eldincarole lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19 |